recent
outbreak
gener
chao
global
health
economi
claimedinfect
larg
number
live
close
resembl
sar
cov
present
strain
manifest
except
higher
degre
spreadabl
virul
stabil
possibl
due
unidentifi
mutat
viral
spike
glycoprotein
like
interact
host
angiotensinconvert
enzym
transmit
genet
materi
hijack
host
machineri
extrem
fidel
self
propag
attempt
made
develop
suitabl
vaccin
blocker
virusreceptor
inhibitor
within
short
period
time
attempt
taken
develop
therapeut
vaccin
strategi
comparison
spike
glycoprotein
among
sarscov
merscov
verifi
structur
qualiti
swissmodel
pymol
topolog
profunc
motif
meme
suit
gene
ontolog
base
conserv
domain
interpro
databas
screen
sever
epitop
svmtrip
sar
base
energet
antigen
regard
possibl
glycosyl
mhcparatop
bind
vaxigen
hawkdock
zdock
server
effect
screen
pair
spike
protein
epitop
region
select
energet
mhc
ii
reactiv
found
good
target
vaccin
possibl
role
glycosyl
epitop
region
show
profound
effect
epitop
recognit
present
work
might
help
urgent
develop
suitabl
vaccin
regimen
sar
introduct
strategi
affect
sensit
person
possibl
medic
immun
exist
drug
infus
convalesc
plasma
conduct
utmost
care
covid
patient
advanc
precautionari
step
therapeut
intervent
formul
take
account
sever
person
commun
factor
develop
success
reproduc
vaccin
protocol
human
trial
may
take
longer
time
issu
mutat
larg
number
glycan
shield
epitop
mask
sar
cov
protein
seri
medic
regimen
blocker
use
reduc
sever
mortal
viru
infect
chloroquin
hydroxychloroquin
prescrib
somewher
fight
time
human
coronavirus
influenza
virus
result
epidem
last
decad
differ
part
world
anomali
sever
spread
origin
site
china
part
world
european
north
america
countri
might
indic
common
human
cov
may
annual
peak
circul
winter
month
us
individu
human
cov
may
show
variabl
circul
year
year
colder
climat
prior
exposur
human
coronavirus
influenza
flu
virus
possibl
vaccin
might
develop
antibodi
depend
enhanc
ade
immunolog
respons
recent
sar
exposur
ade
might
modul
immun
respons
could
elicit
sustain
inflamm
lymphopenia
andor
cytokin
storm
possibl
could
one
reason
histori
exposur
cov
besid
weaker
immun
system
older
peopl
affect
present
sar
moreov
helper
cell
suppressor
cell
patient
normal
level
novel
coronaviru
might
mainli
act
lymphocyt
especi
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
lymphocyt
strong
inflammatori
event
could
initi
collaps
environ
infect
death
case
infect
acut
respiratori
failur
follow
organ
like
kidney
anomali
case
inflammatori
outburst
might
worsen
infect
post
viralincub
situat
recent
studi
experiment
infect
anim
strongli
suggest
crucial
role
virusinduc
immunopatholog
event
caus
fatal
pneumonia
human
cov
infect
combin
antivir
antiinflammatori
treatment
might
benefici
case
sarsbas
avail
immunetherapeut
prophylact
modal
reveal
poor
efficaci
neutral
protect
infect
target
novel
spike
protein
background
critic
screen
spike
sequenc
structur
sar
energet
base
immunoinfrmat
analysi
may
help
develop
suitabl
vaccin
current
studi
intend
analyz
spike
protein
sar
cov
mer
cov
sar
cov
four
earlier
outbreak
human
corona
viru
strain
critic
compar
sar
cov
sar
cov
spikeprotein
domain
motif
screen
sever
epitop
base
energet
antigen
employ
sever
bioimmuuno
informat
softwar
regard
possibl
glycosyl
mhcparatop
bind
effect
present
work
might
help
urgent
develop
suitabl
vaccin
regimen
tertiari
structur
select
coronaviru
cov
spike
protein
predict
valid
use
protein
homologyanalog
recognit
engin
v
swissmodel
structur
predict
experiment
design
protein
fold
predict
structur
subject
analysi
swissmodel
qmean
zscore
calcul
includ
cumul
zscore
atom
solvat
torsion
valu
predict
rampag
ramachandran
plot
analysi
server
use
protein
structur
qualiti
assess
summat
number
residu
favor
region
addit
allow
region
consid
percent
qualiti
assess
predict
tertiari
structur
visual
align
use
pymol
molecular
visual
system
pymol
assign
secondari
structur
use
secondari
structur
align
algorithm
call
dss
sequenc
two
structur
align
first
structur
align
visual
molecul
highspe
raytrac
molecular
graphic
system
use
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
secondari
structur
analysi
fold
pattern
analyz
form
topolog
use
profunc
protein
function
predict
server
use
protein
structur
protein
classif
topolog
analysi
play
independ
effect
altern
tradit
structur
predict
topolog
differ
two
structur
indic
differ
protein
fold
flexibl
sequenc
comparison
among
select
cov
spike
glycoprotein
conduct
multipl
sequenc
align
use
clustal
conserv
motif
identifi
use
meme
suit
http
memesdscedumemecgibinmastcgi
server
meme
suit
repres
ungap
conserv
sequenc
frequent
present
group
relat
sequenc
motif
number
defin
current
studi
motif
find
wherea
tool
use
identif
gap
motif
within
relat
sequenc
conserv
motif
repres
logo
use
tool
meme
suit
server
identifi
motif
subject
annot
use
protein
blast
http
blastncbinlmnihgovblastcgi
programblastp
pagetypeblastsearch
linkloc
blasthom
final
function
gene
ontolog
base
conserv
domain
identif
conduct
use
interpro
classif
protein
famili
interact
databas
conserv
epitop
sar
spike
glycoprotein
identifi
use
svmtrip
tool
predict
linear
antigen
epitop
svmtrip
predict
linier
antigen
epitop
feed
support
vector
machin
tripeptid
similar
propens
score
differ
preanalyz
epitop
data
annot
predict
epitop
perform
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protein
blast
svmtrip
gain
sensit
precis
valu
five
fold
crossvalid
epitop
predict
amino
acid
length
select
major
histocompat
complex
mhc
bind
effici
predict
epitop
perform
use
immun
epitop
databas
iedb
analysi
resourc
total
dpa
dqa
drb
allel
mhc
class
ii
screen
detect
best
interact
allel
basi
highest
consensu
percentil
rank
lowest
valu
analys
perform
human
class
ii
allel
use
frequent
occur
allel
frequenc
peptid
length
select
consensu
percentil
rank
use
select
peptid
antigenec
predict
epitop
determin
use
vaxigen
protect
antigen
tumour
antigen
subunit
vaccin
predict
server
vaxigen
use
auto
cross
covari
acc
transform
select
protein
sequenc
base
uniqu
amino
acid
properti
sequenc
use
find
known
antigen
nonantigen
identifi
sequenc
test
antigenec
leaveoneout
crossvalid
overal
extern
valid
predict
accuraci
structur
mhc
class
ii
hladra
drb
molecul
pdb
id
fulli
glycosyl
covid
spike
protein
structur
pdb
id
retriev
protein
data
bank
pdb
dock
perform
use
hawkdock
zdock
server
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gener
dock
solut
among
best
analyz
base
dock
score
bind
free
energi
valu
calcul
spike
glycoprotein
structur
seven
coronaviru
includ
recent
outbreak
strain
sar
covid
present
tabl
ramachandran
plot
data
structur
align
data
suggest
sar
cov
sar
higher
degre
align
tabl
protein
sequenc
rang
amino
acid
effort
made
epitop
base
peptid
vaccin
develop
search
mhci
ii
class
compat
site
result
yet
come
current
studi
energet
inhibit
base
select
sar
spike
epitop
possibl
glycosyl
effectstructuralhindr
evalu
may
help
urgent
vaccin
strategi
current
disastr
situat
higher
degre
similar
sar
cov
sar
might
indic
help
therapeut
vaccin
strategi
refer
current
global
situat
howev
absolut
higher
degre
virul
spread
natur
sar
great
concern
present
scenario
present
predict
valid
multipl
base
align
pattern
select
sequenc
subject
analysi
differ
conserv
motif
protein
sequenc
total
conserv
motif
analyz
figur
remark
select
spike
glycoprotein
sequenc
shown
motif
sequenc
similar
pattern
conserv
motif
posit
repres
figur
identifi
conserv
motif
individu
subject
protein
blast
epitop
design
conduct
covid
spike
glycoprotein
sequenc
structur
sequenc
analysi
differ
locat
found
also
show
similar
sar
cov
sar
covid
spike
glycoprotein
protein
blast
figur
also
motif
posit
within
spike
glycoprotein
monom
repres
figur
epitop
repres
covid
spike
glycoprotein
found
embed
within
viru
envelop
among
other
motif
found
interior
locat
spike
glycoprotein
monom
motif
found
surfac
structur
could
use
immunolog
target
proper
diagnosi
treatment
covid
import
issu
epitop
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
final
could
confront
factor
possibl
transit
prefus
postfus
spike
structur
distort
specif
mutant
structur
design
test
resist
conform
chang
bind
proteas
cleavag
site
may
indic
search
suitabl
epitop
may
remain
unhind
preto
postfus
state
transit
proper
type
major
histocompat
complex
mhc
select
identifi
covid
epitop
perform
enlist
tabl
epitop
individu
screen
dpa
dqa
drb
allel
mhc
class
ii
best
fit
analysi
analyz
spike
glycoprotein
covid
infecti
particl
transmit
one
infect
individu
anoth
allel
mhc
class
ii
select
viral
epitop
specif
analysi
observ
bind
epitop
sequenc
identifi
basi
valu
among
sequenc
iiaytmslgaensva
epitop
shown
lowest
valu
hand
found
sequenc
timlccmtsccsclk
epitop
siiaytmslgaensv
epitop
highest
consensu
percentil
rank
basi
highest
valu
found
motif
similarli
observ
sequenc
vrdpqtleilditpc
epitop
highest
vsvitpgtntsnqva
epitop
consensu
percentil
rank
valu
individu
mhc
class
ii
molecul
found
other
tabl
threshold
valu
highest
consensu
percentil
rank
select
whole
highest
consensu
percentil
rank
valu
observ
sequenc
qqliraaeirasanl
epitop
lowest
valu
observ
sequenc
iiaytmslgaensva
epitop
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antigen
properti
identifi
target
sequenc
epitop
also
predict
basi
threshold
valu
threshold
valu
sequenc
consid
nonantigen
sequenc
valu
antigen
natur
total
antigen
sequenc
detect
tabl
among
two
sequenc
aaeirasanlaatkm
epitop
itpgtntsnqvavli
epitop
found
higher
threshold
valu
respect
locat
interior
could
use
potent
antigen
accord
epitop
locat
figur
antigen
natur
sequenc
like
b
b
could
target
also
coronaviru
spike
protein
glycosyl
natur
nacetyl
glucosamin
nag
main
compon
glycan
shield
possibl
epitop
mask
observ
may
barrier
proper
immunogen
respons
compar
analysi
glycosyl
nonglycosyl
protein
reveal
structur
modif
epitop
locat
among
identifi
epitop
sequenc
itpgtntsnqvavli
found
n
link
glycosyl
posit
structur
modif
epitop
analyz
use
nonglycosyl
protein
structur
covid
acc
gltcosyl
covid
protein
pdb
id
effect
glycosyl
protein
structur
reveal
glycosyl
conform
organis
figur
nonglycosyl
one
figur
secondari
structur
comparison
two
epitop
show
organis
structur
attach
nag
residu
figur
wherea
shorter
structur
observ
nag
remov
structur
figur
peptid
interact
site
epitop
block
due
nag
attach
result
antibodi
bind
antigen
may
hamper
nag
residu
directli
bind
n
asn
amino
acid
residu
figur
remov
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
nag
spike
glycoprotein
structur
difficult
structur
distort
glycosyl
nonglycosyl
epitop
tertiari
level
indic
remov
nag
may
distort
structur
epitop
figur
may
hamper
proper
antigenantibodi
bind
section
energet
epitop
attach
mhc
class
ii
hladra
drb
determin
presenc
absenc
nag
epitop
structur
molecular
dock
figur
dock
result
show
without
nag
bind
effici
epitop
epitop
bind
site
mhc
class
ii
hladra
drb
molecul
high
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
though
epitop
b
also
present
surfac
spike
glycoprotein
found
wrap
short
segment
igaehvnnsyecd
carri
glycosyl
n
residu
posit
figur
result
antibodi
access
epitop
may
also
difficult
wherea
surfac
epitop
sequenc
vrdpqtleilditpc
show
highest
antigenec
tabl
recombin
gain
entri
human
cell
point
also
note
sar
induc
sever
often
lethal
lung
failur
caus
due
inhibit
express
keep
normal
function
block
viral
entri
challeng
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
posit
epitop
covid
spike
protein
direct
indirect
nag
attach
pdb
id
b
among
best
dock
posit
found
epitop
present
site
mhc
ii
pdb
id
c
best
dock
postur
epitop
mhc
ii
specif
interact
pattern
e
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
